Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Polman

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 26, 2004
The therapeutic value of cannabinoids in MS: real or imaginary?Joep Killestein, Chris Polman
Lancet (London, England)|March 3, 2009
Improving function: a new treatment era for multiple sclerosis?Alan Thompson, Chris Polman
Neurology|February 23, 2011
Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapyReinhard Hohlfeld, Frederik Barkhof, Chris Polman
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 13, 2006
Neutralizing antibodies to interferon-beta may persist after cessation of therapy: what impact could they have?Chris Polman, Huub Schellekens, Joep Killestein
The Lancet. Neurology|December 29, 2004
Biological markers in CSF and blood for axonal degeneration in multiple sclerosisCharlotte E Teunissen, Christine Dijkstra, Chris Polman
JAMA Neurology|November 7, 2012
Natalizumab: bench to bedside and beyondRichard Rudick, Chris Polman, David Clifford, et al.
Neuroscience and Biobehavioral Reviews|September 7, 2005
Pain in Parkinson's disease and multiple sclerosis: its relation to the medial and lateral pain systemsErik Scherder, Erik Wolters, Chris Polman, et al.
The Lancet. Neurology|August 28, 2003
Spinal-cord MRI in multiple sclerosisGeert Lycklama, Alan Thompson, Massimo Filippi, et al.
Archives of Neurology|January 11, 2007
Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosisLars Bö, Jeroen J G Geurts, Paul van der Valk, et al.
Lancet (London, England)|February 25, 2003
Interferons in relapsing remitting multiple sclerosis: a systematic reviewGraziella Filippini, Luca Munari, Barbara Incorvaia, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 26, 2004
The therapeutic value of cannabinoids in MS: real or imaginary?Joep Killestein, Chris Polman
Lancet (London, England)|March 3, 2009
Improving function: a new treatment era for multiple sclerosis?Alan Thompson, Chris Polman
Neurology|February 23, 2011
Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapyReinhard Hohlfeld, Frederik Barkhof, Chris Polman
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 13, 2006
Neutralizing antibodies to interferon-beta may persist after cessation of therapy: what impact could they have?Chris Polman, Huub Schellekens, Joep Killestein
The Lancet. Neurology|December 29, 2004
Biological markers in CSF and blood for axonal degeneration in multiple sclerosisCharlotte E Teunissen, Christine Dijkstra, Chris Polman
JAMA Neurology|November 7, 2012
Natalizumab: bench to bedside and beyondRichard Rudick, Chris Polman, David Clifford, et al.
Neuroscience and Biobehavioral Reviews|September 7, 2005
Pain in Parkinson's disease and multiple sclerosis: its relation to the medial and lateral pain systemsErik Scherder, Erik Wolters, Chris Polman, et al.
The Lancet. Neurology|August 28, 2003
Spinal-cord MRI in multiple sclerosisGeert Lycklama, Alan Thompson, Massimo Filippi, et al.
Archives of Neurology|January 11, 2007
Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosisLars Bö, Jeroen J G Geurts, Paul van der Valk, et al.
Lancet (London, England)|February 25, 2003
Interferons in relapsing remitting multiple sclerosis: a systematic reviewGraziella Filippini, Luca Munari, Barbara Incorvaia, et al.
Pageof 5